Sporadic primary hyperparathyroidism in young patients: a separate disease entity?

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 10367876)

Published in Arch Surg on June 01, 1999

Authors

C R Harman1, J A van Heerden, D R Farley, C S Grant, G B Thompson, K Curlee

Author Affiliations

1: Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minn 55905, USA.

Articles citing this

Primary hyperparathyroidism in children and adolescents. J Chin Med Assoc (2012) 1.04

Primary hyperparathyroidism in the young age group: particularities of diagnostic and therapeutic schemes. World J Surg (2004) 0.93

Primary hyperparathyroidism in adolescents: the same but different. Pediatr Surg Int (2012) 0.88

Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism. World J Surg (2008) 0.86

Extensive brown tumors caused by parathyroid adenoma in an adolescent patient. Eur J Pediatr (2007) 0.85

Outcomes of minimally invasive parathyroidectomy in pediatric patients with primary hyperparathyroidism owing to parathyroid adenoma: A single institution experience. J Pediatr Surg (2016) 0.80

Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World J Surg (2010) 0.79

A meta-analysis comparing the biochemistry of primary hyperparathyroidism in youths to the biochemistry of primary hyperparathyroidism in adults. J Clin Endocrinol Metab (2014) 0.77

A case of adolescent giant parathyroid adenoma presenting multiple osteolytic fractures and postoperative hungry bone syndrome. Clin Case Rep (2015) 0.77

The changing pattern of diagnosing primary hyperparathyroidism in young patients. Am J Surg (2016) 0.75

Posterior fossa arachnoid cyst masking a delayed diagnosis of hyperparathyroidism in a child. Case Rep Endocrinol (2012) 0.75

A case of acute psychosis in an adolescent male. Case Rep Endocrinol (2014) 0.75

Does multiple gland disease in primary hyperparathyroidism correlate with age or sex? Langenbecks Arch Surg (2009) 0.75

Articles by these authors

Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery (1993) 4.32

Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg (1995) 4.17

Metastasis to the thyroid gland. A report of 43 cases. Cancer (1997) 4.08

Resection of hepatic metastases from colorectal cancer. Arch Surg (1984) 4.06

Complications following pancreaticoduodenectomy. Current management. Arch Surg (1992) 3.94

Adenocarcinoma of the stomach: are we making progress? Lancet (1993) 3.68

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst (2001) 3.37

Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab (2001) 3.19

Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg (1992) 3.05

Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg (1992) 2.97

Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery (2001) 2.50

Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50

Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42

Primary hepatic malignancy: surgical management and determinants of survival. Surgery (1989) 2.35

Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J Clin Endocrinol Metab (1999) 2.06

Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery (1992) 2.06

Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05

Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1991) 2.04

What prognostic factors are important in duodenal adenocarcinoma? Arch Surg (2000) 2.03

The spectrum of serous cystadenoma of the pancreas. Clinical, pathologic, and surgical aspects. Ann Surg (1992) 1.96

Total pancreatectomy for ductal adenocarcinoma of the pancreas. Mayo Clinic experience. Am J Surg (1981) 1.90

Clinical spectrum and outcome of functional extraadrenal paraganglioma. World J Surg (1996) 1.88

Nonpancreatic primary tumors with metastasis to the pancreas. Surg Gynecol Obstet (1989) 1.85

Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA (1980) 1.85

Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1986) 1.84

Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc (1990) 1.80

Prospective evaluation of Roux-en-Y gastric bypass as primary operation for medically complicated obesity. Mayo Clin Proc (2000) 1.74

Neuroendocrine ampullary tumors: spectrum of disease including the first report of a neuroendocrine carcinoma of non-small cell type. Surgery (1994) 1.72

Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys (1993) 1.71

Anastomotic ulceration following subtotal and total pancreatectomy. Ann Surg (1979) 1.69

Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol (1999) 1.69

Long-term consequences of intraoperative spillage of bile and gallstones during laparoscopic cholecystectomy. J Gastrointest Surg (2006) 1.68

The significance of sinistral portal hypertension complicating chronic pancreatitis. Am J Surg (2000) 1.67

Reexploration for symptomatic hematomas after cervical exploration. Surgery (2001) 1.66

Survival after surgical treatment for primary hyperparathyroidism. Surgery (1997) 1.66

Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg (2001) 1.64

Carcinoid tumors of the gastrointestinal tract: presentation, management, and prognosis. Surgery (1985) 1.64

Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol (2001) 1.63

Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery (2000) 1.63

Treatment of pyogenic hepatic abscesses. Surgical vs percutaneous drainage. Arch Surg (1986) 1.63

Pancreatic resection for carcinoma of the pancreas: Whipple versus total pancreatectomy--an institutional perspective. World J Surg (1984) 1.61

Percutaneous cholecystostomy: a valuable technique in high-risk patients with presumed acute cholecystitis. Br J Surg (1995) 1.60

Carcinoma of the body and tail of the pancreas: is curative resection justified? Surgery (1992) 1.59

Contralateral metachronous inguinal hernias in adults: role for prophylaxis during the TEP repair. Hernia (2011) 1.58

Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med (2001) 1.58

Surgical management of hepatic hydatid disease. Mayo Clin Proc (1991) 1.57

Primary thyroid lymphoma. Semin Oncol (1999) 1.57

Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey. Med Care (1991) 1.56

Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg (1992) 1.53

A study of metastatic cancer found during inguinal hernia repair. Cancer (1992) 1.51

Intraoperative monitoring of parathyroid procedures by a 15-minute parathyroid hormone immunochemiluminometric assay. Mayo Clin Proc (1994) 1.50

Results of reoperation for hyperparathyroidism, with evaluation of preoperative localization studies. Surgery (1978) 1.50

Radical resection for carcinoma of the ampulla of Vater. Arch Surg (1991) 1.49

The pathology and surgical management of primary hyperparathyroidism. Surg Clin North Am (1977) 1.48

Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery (1990) 1.47

Carcinoma of the gallbladder. Does radical resection improve outcome? Arch Surg (1990) 1.45

Postoperative reflux gastritis. Am J Surg (1975) 1.45

Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery (1988) 1.44

Prognosis of symptomatic duodenal adenomas in familial adenomatous polyposis. Arch Surg (1991) 1.44

Cancer of the parathyroid glands. Arch Surg (1979) 1.44

Pheochromocytoma: current status and changing trends. Surgery (1982) 1.44

Incidentally discovered adrenal tumors: an institutional perspective. Surgery (1991) 1.43

Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery (1994) 1.41

Are concomitant surgical procedures acceptable in patients undergoing cervical exploration for primary hyperparathyroidism? Mayo Clin Proc (1991) 1.41

Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery (1997) 1.40

Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg (1996) 1.39

Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm". Mayo Clin Proc (1997) 1.38